Overview A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348 Status: Completed Trial end date: 2021-01-15 Target enrollment: Participant gender: Summary A Clinical Trial to evaluate the Pharmacokinetics and Tolerability of CKD-348 Phase: Phase 1 Details Lead Sponsor: Chong Kun Dang Pharmaceutical